Published in JACC Cardiovasc Interv on June 01, 2008
Recanalisation of coronary chronic total occlusions with new techniques including the retrograde approach via collaterals. Neth Heart J (2011) 0.91
Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in Chronic Total Occlusions in One Year Follow-Up. Cardiol Res (2013) 0.78
Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study. Heart Vessels (2015) 0.77
Multimodality imaging evaluation of functional and clinical benefits of percutaneous coronary intervention in patients with chronic total occlusion lesion. Theranostics (2012) 0.76
Guidewires used in first intentional single wiring strategy for chronic total occlusions of the left anterior descending coronary artery. Heart Views (2013) 0.75
The evidence base for revascularisation of chronic total occlusions. Curr Cardiol Rev (2014) 0.75
Radial approach and single wiring as first intentional strategies in chronic total occlusions of the left anterior descending coronary artery. J Saudi Heart Assoc (2013) 0.75
Improved survival after percutaneous coronary intervention of chronic total occlusion varies by target vessel. JACC Cardiovasc Interv (2008) 0.75
Revascularization of a chronically occluded left anterior descending artery: is it worth all the effort? JACC Cardiovasc Interv (2008) 0.75
A prospective natural-history study of coronary atherosclerosis. N Engl J Med (2011) 10.66
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med (2002) 4.25
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med (2010) 3.42
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation (2008) 3.19
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol (2005) 2.81
Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest (2003) 2.40
The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011). J Am Coll Cardiol (2012) 2.31
Chronic total occlusion angioplasty in the United States. JACC Cardiovasc Interv (2009) 2.24
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol (2004) 2.14
Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv (2009) 2.03
Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation (2002) 2.00
A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv (2012) 1.95
Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization. Circulation (2007) 1.67
The efficacy of "hybrid" percutaneous coronary intervention in chronic total occlusions caused by in-stent restenosis: insights from a US multicenter registry. Catheter Cardiovasc Interv (2014) 1.64
Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv (2009) 1.62
Diabetes duration is associated with increased thin-cap fibroatheroma detected by intravascular ultrasound with virtual histology. Circ Cardiovasc Interv (2009) 1.59
Percutaneous coronary intervention use in the United States: defining measures of appropriateness. JACC Cardiovasc Interv (2012) 1.54
Quality of life benefits of percutaneous coronary intervention for chronic occlusions. Catheter Cardiovasc Interv (2013) 1.52
Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv (2011) 1.47
Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years. Am Heart J (2003) 1.47
Costs of transradial percutaneous coronary intervention. JACC Cardiovasc Interv (2013) 1.47
Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study. Coron Artery Dis (2014) 1.47
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). Am J Cardiol (2005) 1.47
Treatment of the chronic total occlusion: a call to action for the interventional community. Catheter Cardiovasc Interv (2014) 1.46
Low-to-moderate alcohol intake and health status in heart failure patients. J Card Fail (2005) 1.44
Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis. EuroIntervention (2011) 1.40
Percutaneous coronary interventions and cardiovascular outcomes for patients with chronic total occlusions: another single center retrospective adds clarity or controversy? Catheter Cardiovasc Interv (2012) 1.39
Use of Saphenous Vein Bypass Grafts for Retrograde Recanalization of Coronary Chronic Total Occlusions: Insights From a Multicenter Registry. J Invasive Cardiol (2016) 1.39
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation (2003) 1.38
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial. Catheter Cardiovasc Interv (2008) 1.38
Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J (2004) 1.38
The retrograde technique for recanalization of chronic total occlusions: a step-by-step approach. JACC Cardiovasc Interv (2012) 1.32
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol (2002) 1.30
Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail (2004) 1.27
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv (2011) 1.26
The retrograde approach to coronary artery chronic total occlusions: a practical approach. Catheter Cardiovasc Interv (2011) 1.22
Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry. J Am Coll Cardiol (2012) 1.17
Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 1.17
Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol (2004) 1.09
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol (2007) 1.09
Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. Am Heart J (2005) 1.08
Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA (2013) 1.08
Not all subintimal chronic total occlusion revascularization is alike. J Am Coll Cardiol (2013) 1.07
Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging (2012) 1.04
A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass. Ann Thorac Surg (2002) 1.04
Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding. Circ Cardiovasc Qual Outcomes (2010) 1.02
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc Interv (2009) 1.02
Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unit. Endocr Pract (2013) 1.00
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv (2010) 0.99
Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes. JACC Cardiovasc Imaging (2012) 0.99
Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studies. Diab Vasc Dis Res (2011) 0.98
Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention. J Am Coll Cardiol (2013) 0.97
Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque. Eur Heart J (2007) 0.92
Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol (2003) 0.90
Disparity in drug-eluting stent utilization by insurance type. Am Heart J (2008) 0.90
Steatosis and diastolic dysfunction: the skinny on myocardial fat. J Am Coll Cardiol (2008) 0.89
Limitations to the use of virtual histology-intravascular ultrasound to detect vulnerable plaque. Eur Heart J (2007) 0.89
Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intervention: analysis from the national cardiovascular data registry. Circ Cardiovasc Interv (2013) 0.88
Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry. Eur Heart J (2009) 0.86
Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries. Diabetes Care (2008) 0.86
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol (2006) 0.86
Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol (2007) 0.85
LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. Pancreas (2014) 0.85
Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events (from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study). Am J Cardiol (2012) 0.84
Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. JACC Cardiovasc Interv (2012) 0.84
In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am J Cardiol (2005) 0.84
Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population. Diabetes Care (2006) 0.83
The impact of bivalirudin on percutaneous coronary intervention-related bleeding. EuroIntervention (2010) 0.83
Success rates of percutaneous coronary intervention of chronic total occlusions and long-term survival in patients with diabetes mellitus. Diab Vasc Dis Res (2006) 0.82
Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality. Eur Heart J (2003) 0.82
The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis. Diab Vasc Dis Res (2009) 0.82
Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome. BMC Med Genet (2011) 0.81
Diabetes mellitus is associated with plaque classified as thin cap fibroatheroma: an intravascular ultrasound study. Diab Vasc Dis Res (2009) 0.81
Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®. Am Heart J (2012) 0.81
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv (2011) 0.81
Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure. Eur J Heart Fail (2015) 0.80
Effect of renal transplantation for chronic renal disease on left ventricular mass. Am J Cardiol (2012) 0.80
Comparison of bleeding complications using arterial closure device versus manual compression by propensity matching in patients undergoing percutaneous coronary intervention. Am J Cardiol (2011) 0.79
Prevalence of grade II and III obesity among patients hospitalized with cardiovascular diagnoses in 2002 v. 2009. Mo Med (2012) 0.79